Profile: Shire Specialty Pharmaceuticals is a global specialty pharmaceutical company. We focus on developing projects and marketing products in the areas of the central nervous system, gastrointestinal & renal diseases. Agrylin is indicated for the treatment of essential thrombocythaemia, secondary to a myeloproliferative disorder. Dynepo is indicated for the treatment of anaemia in patients with chronic renal failure.
FDA Registration Number: 3012962138
3 Products/Services (Click for related suppliers)
|
• Cardiovasculars |
• Pharmaceutical Market Research |
• Pharmaceuticals |